Skip to main content
Download PDF

Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm

Orphanet Journal of Rare Diseases volume 14, Article number: 111 (2019) Cite this article

The Original Article was published on 17 January 2018

Correction to: Orphanet Journal of Rare Diseases (2018) 13:6

https://doi.org/10.1186/s13023-017-0726-x

The authors would like to rectify the following errors in their published article [1]:

In Fig. 3 of the article (page 7 of the PDF), ‘Val30Met’ should be omitted from the figure legend, which should instead read: ‘Red-flag symptom clusters specific to ATTR-FAP in Japan…’.

Similarly, in Fig. 5 of the article (page 10 of the PDF), ‘Val30Met’ should be omitted from the figure legend, which should instead read: ‘Treatment algorithm specific to ATTR-FAP in Japan…’.

The authors believe that the applicability of the red-flag symptom clusters and treatment algorithm for this disease should not be limited to the Val30Met mutation and would like to present this with this Correction article.

Furthermore, in Fig. 5 of the article (page 10 of the PDF), the treatment algorithm, ‘Modified body mass index (mBMI) <600’, listed as the 2nd bullet under ‘Evaluate for conventional LT indications’, should be changed to ‘Modified body mass index (mBMI) >600’.

This error occurred due to an inadvertent oversight.

Reference

  1. Sekijima et al., Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet Journal of Rare Diseases (2018) 13:6 https://doi.org/10.1186/s13023-017-0726-x.

Download references

Author information

Authors and Affiliations

  1. Department of Medicine (Neurology and Rheumatology), Shinshu University School of Medicine, Matsumoto, Japan

    Yoshiki Sekijima

  2. Department of Neurology, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-ku, Kumamoto-shi, Kumamoto, 860-8556, Japan

    Mitsuharu Ueda & Yukio Ando

  3. Department of Neurology, Nagoya University Graduate School of Medicine, Nagoya, Japan

    Haruki Koike

  4. Department of Neurology, Graduate School of Medicine, Chiba University, Chiba, Japan

    Sonoko Misawa

  5. Pfizer Japan Inc., Tokyo, Japan

    Tomonori Ishii

Authors
  1. Yoshiki Sekijima
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mitsuharu Ueda
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Haruki Koike
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Sonoko Misawa
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tomonori Ishii
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yukio Ando
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yukio Ando.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sekijima, Y., Ueda, M., Koike, H. et al. Correction to: Diagnosis and management of transthyretin familial amyloid polyneuropathy in Japan: red-flag symptom clusters and treatment algorithm. Orphanet J Rare Dis 14, 111 (2019). https://doi.org/10.1186/s13023-019-1092-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s13023-019-1092-7

Orphanet Journal of Rare Diseases

ISSN: 1750-1172